<DOC>
	<DOCNO>NCT00662844</DOCNO>
	<brief_summary>That average require vitamin D dose 1700IU/day increase serum 25hydroxyvitamin D level 20 30ng/ml young Caucasian woman dose 1860 2480 IU/day African American</brief_summary>
	<brief_title>Vitamin D Supplementation Younger Women</brief_title>
	<detailed_description>Vitamin D unique nutrient requirement meet endogenous production sun diet , make difficult determine actual requirement nutrient . The current recommend dietary reference intake ( DRI ) vitamin D 200 IU adult 25- 50 year , 400 IU adult 51-70 year 600 IU adult 70 year age . In view many scientist field vitamin D , current DRI vitamin D low . This mainly increase prevalence vitamin D deficiency observe population base measure serum 25OHD level . It recognize serum 25OHD indicator vitamin D status . There grow consensus serum 25OHD concentration least 30-32 ng/ml need reduce serum Parathyroid hormone ( PTH ) reduce bone loss . Also , research last two decade provide additional evidence high vitamin D level ( 25OHD 30ng/ml ) necessary optimum overall health prevent disease . There clear view amount vitamin D intake require maintain optimum level serum 25OHD level population age systematic dose response study vitamin D woman age . A study carry different sex age group suggest untreated subject serum 25OHD concentration 20 ng/ml would need daily dose ~1700 IU/d Vitamin D3 reach serum 25OHD 32 ng/ml Caucasians , African Americans Vitamin D3 requirement would higher - 1860-2480 IU/d . The current proposal aim study dose response effect vitamin D3 400 IU , 800 IU,1600 IU 2400 IU placebo serum 25OHD serum PTH young woman vitamin D insufficiency ( serum 25OHD &lt; 20 ng/ml ) adequate calcium intake 1000mg/day . Another aim study establish minimum effective dose vitamin D3 Normalizes PTH Caucasian African American young woman . Vitamin D dose reduces serum PTH normal level 97 % normal population recommend dietary allowance . We also establish safety high dos vitamin D supplementation relate hypercalcemia/hypercalcuria .</detailed_description>
	<mesh_term>Avitaminosis</mesh_term>
	<mesh_term>Rickets</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>1 . Premenopausal woman , minimum age 25 year , maximum age 45 year . ( Women hysterectomy and/or oophorectomy must premenopausal FSH level . ) 2 . Serum 25OHD level : 5 20 ng/ml 3 . BMI &lt; 45 kg/m2 . 4 . Willing discontinue vitamin D supplement enter study . 5 . Negative pregnancy test BMD calcium absorption test . 6 . Willing give sign informed consent form 7 . Subject Caucasian African American 1 . Cancer ( exception : basal cell carcinoma cancer occur 10 year ago ) terminal illness . 2 . Previous hip fracture . 3 . Hemiplegia . 4 . Uncontrolled type I diabetes Â± significant proteinuria fast blood sugar &gt; 140 mg type II diabetes . 5 . Kidney stone &gt; 2 lifetime . 6 . Chronic renal failure ( serum creatinine &gt; 1.4 mg/dl ) . 7 . Evidence chronic liver disease , include alcoholism . 8 . Physical condition severe osteoarthritis , rheumatoid arthritis , heart failure severe enough prevent reasonable physical activity . 9 . Previous treatment bisphosphonates ( 3 month ) , PTH PTH derivative , ( e.g . Teriparatide ) Fluoride last 6 month . 10 . Previous treatment within last 6 month calcitonin estrogen ( except birth control pill ) . 11 . Chronic high dose corticosteroid therapy ( &gt; 10 mg/day ) 6 month within last 6 month . 12 . Anticonvulsant therapy . ( Dilantin , Phenobarbital ) 13 . High dose thiazide therapy ( &gt; 37.5 mg ) . 14 . 24 hour urine calcium &gt; 290 mg 2 baseline test . 15 . Serum calcium exceed upper normal limit 2 baseline test . 16 . BMD . Tscore le 3.0 spine hip .</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Vitamin D insufficiency , vitamin D3 treatment , young woman</keyword>
</DOC>